Diferencia entre revisiones de «Template:Meningitis Antibiotics»

Sin resumen de edición
Línea 10: Línea 10:
*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily
*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily
*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''
*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''
**'''[[Vancomycin]] is for resistant [Pneumococcus]])'''
**'''[[Vancomycin]] is for resistant [[Pneumococcus]]'''
 


===Post Procedural (or penetrating trauma)===
===Post Procedural (or penetrating trauma)===

Revisión del 00:39 23 abr 2015

Treatment guidelines based on van de Beek et al[1]

Neonates (up to 1 month of age)

MRSA is uncommon in the neonate


> 1 month to Adult

Post Procedural (or penetrating trauma)


Cryptococcosis Meningitis

Options

  • Amphotericin B 1mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily
  • Amphotericin B 5mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily


Neisseria meningitidis Prophylaxis

  • Ceftriaxone 250mg IM once (if less than 15yr then 125mg IM)
  • Ciprofloxacin 500mg PO once
  • Rifampin 600 mg PO BID x 2 days
    • if < 1 month old then 5mg/kg PO BID x 2 days
    • if ≥ 1 month old then 10mg/kg (max at 600mg) PO BID x 2 days

Meningitis with severe PCN allergy

Age >50y

  1. van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702